BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 18292720)

  • 21. Effect of bariatric surgery on peripheral blood lymphocyte subsets in women.
    Merhi ZO; Durkin HG; Feldman J; Macura J; Rodriguez C; Minkoff H
    Surg Obes Relat Dis; 2009; 5(2):165-71. PubMed ID: 18996763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peripheral CD8(+) T cell proliferation is prognostic for patients with advanced thoracic malignancies.
    McCoy MJ; Nowak AK; van der Most RG; Dick IM; Lake RA
    Cancer Immunol Immunother; 2013 Mar; 62(3):529-39. PubMed ID: 23069871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reciprocal CD4+ T-cell balance of effector CD62Llow CD4+ and CD62LhighCD25+ CD4+ regulatory T cells in small cell lung cancer reflects disease stage.
    Koyama K; Kagamu H; Miura S; Hiura T; Miyabayashi T; Itoh R; Kuriyama H; Tanaka H; Tanaka J; Yoshizawa H; Nakata K; Gejyo F
    Clin Cancer Res; 2008 Nov; 14(21):6770-9. PubMed ID: 18980970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The favorable prognostic significance of atelectasis in patients with advanced non-small cell lung cancer: results of a prospective observational study.
    Dediu M; Crisan E; Radut M; Tarlea A; Median D; Alexandru A; Vremes G; Gal C
    Lung Cancer; 2009 Feb; 63(2):271-6. PubMed ID: 18565617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical significance of HLA class I alleles on postoperative prognosis of lung cancer patients in Japan.
    Nagata Y; Hanagiri T; Mizukami M; Kuroda K; Shigematsu Y; Baba T; Ichiki Y; Yasuda M; So T; Takenoyama M; Sugio K; Nagashima A; Yasumoto K
    Lung Cancer; 2009 Jul; 65(1):91-7. PubMed ID: 19054590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired CD4 and CD8 effector function and decreased memory T cell populations in ICOS-deficient patients.
    Takahashi N; Matsumoto K; Saito H; Nanki T; Miyasaka N; Kobata T; Azuma M; Lee SK; Mizutani S; Morio T
    J Immunol; 2009 May; 182(9):5515-27. PubMed ID: 19380800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Presence of tumor-infiltrating lymphocytes is an independent prognostic factor in type I and II endometrial cancer.
    de Jong RA; Leffers N; Boezen HM; ten Hoor KA; van der Zee AG; Hollema H; Nijman HW
    Gynecol Oncol; 2009 Jul; 114(1):105-10. PubMed ID: 19411095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival.
    Liao WT; Wang X; Xu LH; Kong QL; Yu CP; Li MZ; Shi L; Zeng MS; Song LB
    Cancer; 2009 Apr; 115(7):1507-17. PubMed ID: 19170237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Favorable surgical results for patients with nonsmall cell lung cancer over 80 years old: a multicenter survey.
    Suemitsu R; Yamaguchi M; Takeo S; Ondo K; Ueda H; Yoshino I; Maehara Y
    Ann Thorac Cardiovasc Surg; 2008 Jun; 14(3):154-60. PubMed ID: 18577893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of tumor-specific T lymphocytes after laser-induced thermotherapy in patients with colorectal liver metastases.
    Vogl TJ; Wissniowski TT; Naguib NN; Hammerstingl RM; Mack MG; Münch S; Ocker M; Strobel D; Hahn EG; Hänsler J
    Cancer Immunol Immunother; 2009 Oct; 58(10):1557-63. PubMed ID: 19184001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of surgical-pathologic N1 lymph node involvement in non-small cell lung cancer.
    Demir A; Turna A; Kocaturk C; Gunluoglu MZ; Aydogmus U; Urer N; Bedirhan MA; Gurses A; Dincer SI
    Ann Thorac Surg; 2009 Apr; 87(4):1014-22. PubMed ID: 19324121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low socioeconomic status is a poor prognostic factor for survival in stage I nonsmall cell lung cancer and is independent of surgical treatment, race, and marital status.
    Ou SH; Zell JA; Ziogas A; Anton-Culver H
    Cancer; 2008 May; 112(9):2011-20. PubMed ID: 18361399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of blood transfusions and preoperative anemia on long-term survival in patients operated for non-small cell lung cancer.
    Panagopoulos ND; Karakantza M; Koletsis E; Apostolakis E; Sakellaropoulos GC; Filos KS; Eleni T; Dougenis D
    Lung Cancer; 2008 Nov; 62(2):273-80. PubMed ID: 18430486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High dose cyclophosphamide preferentially targets naïve T (CD45/CD4/RA+) cells in CIDP and MS patients.
    Gladstone DE; Golightly MG; Brannagan TH
    J Neuroimmunol; 2007 Oct; 190(1-2):121-6. PubMed ID: 17854912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer.
    Leffers N; Gooden MJ; de Jong RA; Hoogeboom BN; ten Hoor KA; Hollema H; Boezen HM; van der Zee AG; Daemen T; Nijman HW
    Cancer Immunol Immunother; 2009 Mar; 58(3):449-59. PubMed ID: 18791714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer.
    Kang CH; Ra YJ; Kim YT; Jheon SH; Sung SW; Kim JH
    Ann Thorac Surg; 2008 Oct; 86(4):1092-7. PubMed ID: 18805138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of ERCC1 and class III beta-tubulin in non-small cell lung cancer patients treated with carboplatin and paclitaxel.
    Azuma K; Sasada T; Kawahara A; Takamori S; Hattori S; Ikeda J; Itoh K; Yamada A; Kage M; Kuwano M; Aizawa H
    Lung Cancer; 2009 Jun; 64(3):326-33. PubMed ID: 18977553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is there a subset of patients with preoperatively diagnosed N2 non-small cell lung cancer who might benefit from surgical resection?
    Ratto GB; Costa R; Maineri P; Alloisio A; Bruzzi P; Dozin B
    J Thorac Cardiovasc Surg; 2009 Oct; 138(4):849-58. PubMed ID: 19660370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The significance of one-station N2 disease in the prognosis of patients with nonsmall-cell lung cancer.
    Misthos P; Sepsas E; Kokotsakis J; Skottis I; Lioulias A
    Ann Thorac Surg; 2008 Nov; 86(5):1626-30. PubMed ID: 19049761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Never-smoking nonsmall cell lung cancer as a separate entity: clinicopathologic features and survival.
    Yano T; Miura N; Takenaka T; Haro A; Okazaki H; Ohba T; Kouso H; Kometani T; Shoji F; Maehara Y
    Cancer; 2008 Sep; 113(5):1012-8. PubMed ID: 18618510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.